Disclosure Of First-Time Adoption [Text Block]

Mithra Pharmaceuticals S.A. - Filing #3183075

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
Disclosure of first-time adoption [text block]
Disclosure of comparative information prepared under previous GAAP [text block]
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity
33 687 EUR
19 934 EUR
396 254 EUR
41 228 EUR
408 647 EUR
336 633 EUR
2 545 EUR
340 769 EUR
33 840 EUR
32 250 EUR
219 759 EUR
332 535 EUR
31 271 EUR
13 690 EUR
157 737 EUR
Comprehensive income
- EUR
18 298 EUR
77 918 EUR
59 620 EUR
- EUR
17 300 EUR
- EUR
- EUR
134 175 EUR
116 875 EUR
Profit (loss)
59 620 EUR
59 620 EUR
116 875 EUR
116 875 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.